Biotech Next Gen 2021 has ended

Create Your Own Event

Biotech Next Gen 2021

#1

What's next in gene therapy

#2

What’s the next target in oncology?

#3

Who's next in biotech and pharma?

#4

Executive Interview: Dave Lennon, President, Novartis Gene Therapies

#5

The New Path to Market for Emerging Biotech

#6

Executive Interview: Sebastian Guth, Ph.D., President, Americas Region, Bayer Pharmaceuticals & Brian Cantwell, Vice President, Digital Strategy, Bayer Pharmaceuticals

#7

New trends shaping biopharma manufacturing

#8

Executive Interview: Mark Wildgust, Ph.D., Vice President, Global Medical Affairs, Oncology, Janssen

#9

Manufacturing of new modalities: New opportunities come with new challenges

#10

Digital Acceleration: Using Data and Technology to Solve Some of Health Care’s Toughest Challenges

#11

Executive Interview: Marcio Souza, CEO, Praxis Precision Medicines

#12

Enabling base editing research via automation and a cloud connected lab

#13

Executive Interview: Mike Riley, Region President, North America, Catalent Biologics

#14

Executive Interview: Trevor Page, Chief Business Officer, Companion Diagnostics, Agilent Technologies

#15

Open for Networking

#16

Executive Interview: Debanjan Ray, CEO, Synthekine

#17

Modernizing the delivery of healthcare with Chrome Enterprise

#18

Executive Interview: Ardy Arianpour, CEO and Co-Founder, Seqster

#19

Lunch Break and Networking

#20

Open for Networking